Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-106217

Options or other derivatives

  • Vice President & Secretary acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SEGALL JUDITH · Vice President & Secretary

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-20 Grant or award : show line 1 in the form Option to Purchase Common Shares +25,000 $2.50 2026-01-19 25,000 25,000 D
Loading xslF345X03/doc4.xml…